Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung
Abstract Small-cell carcinoma of the esophagus (SCCE) is a rare and aggressive cancer. Although several consistent genomic changes were observed previously between SCCE and small-cell lung cancer (SCLC), detailed mutational landscapes revealing discrepancies in genetic underpinnings of tumorigenesis...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03754-0 |
id |
doaj-f9aa163cc7a14043bdb7cfd0927dc3b9 |
---|---|
record_format |
Article |
spelling |
doaj-f9aa163cc7a14043bdb7cfd0927dc3b92021-05-16T11:04:57ZengNature Publishing GroupCell Death and Disease2041-48892021-05-011251810.1038/s41419-021-03754-0Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lungZhengbo Song0Yueping Liu1Guoping Cheng2Lianpeng Chang3Zicheng Yu4Ming Chen5Gang Chen6Department of Clinical Trial, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of SciencesDepartment of Pathology, Hebei Cancer HospitalDepartment of Pathology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of SciencesGeneplus-Beijing InstituteGeneplus-Beijing InstituteDepartment of Radiotherapy, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of SciencesDepartment of Pathology, Fujian Medical University Cancer Hospital and Fujian Cancer HospitalAbstract Small-cell carcinoma of the esophagus (SCCE) is a rare and aggressive cancer. Although several consistent genomic changes were observed previously between SCCE and small-cell lung cancer (SCLC), detailed mutational landscapes revealing discrepancies in genetic underpinnings of tumorigenesis between these two cancers are scarce, and little attention has been paid to answer whether these genetic alterations were related to the prognosis. Herein by performing whole-exome sequencing of 48 SCCE and 64 SCLC tumor samples, respectively we have shown that the number of driver mutations in SCCE was significantly lower than in SCLC (p = 0.0042). In SCCE, 46% of recurrent driver mutations were clonal, which occurred at an early stage during tumorigenesis, while 16 driver mutations were found clonal in SCLC. NOTCH1/3, PIK3CA, and ATM were specifically clonal in SCCE, while TP53 was clonal in SCLC. The total number of clonal mutations differed between two cancers and presented lower in SCCE compared to SCLC (p = 0.0036). Moreover, overall survival (OS) was shorter in patients with higher numbers of clonal mutations for both cancers. In summary, SCCE showed distinct mutational background and clonal architecture compared with SCLC. Organ-specific clonal events revealed different molecular mechanisms underlying tumorigenesis, tumor development, patients’ prognosis, and possible variations in therapeutic outcomes to candidate treatments.https://doi.org/10.1038/s41419-021-03754-0 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhengbo Song Yueping Liu Guoping Cheng Lianpeng Chang Zicheng Yu Ming Chen Gang Chen |
spellingShingle |
Zhengbo Song Yueping Liu Guoping Cheng Lianpeng Chang Zicheng Yu Ming Chen Gang Chen Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung Cell Death and Disease |
author_facet |
Zhengbo Song Yueping Liu Guoping Cheng Lianpeng Chang Zicheng Yu Ming Chen Gang Chen |
author_sort |
Zhengbo Song |
title |
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
title_short |
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
title_full |
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
title_fullStr |
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
title_full_unstemmed |
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
title_sort |
distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung |
publisher |
Nature Publishing Group |
series |
Cell Death and Disease |
issn |
2041-4889 |
publishDate |
2021-05-01 |
description |
Abstract Small-cell carcinoma of the esophagus (SCCE) is a rare and aggressive cancer. Although several consistent genomic changes were observed previously between SCCE and small-cell lung cancer (SCLC), detailed mutational landscapes revealing discrepancies in genetic underpinnings of tumorigenesis between these two cancers are scarce, and little attention has been paid to answer whether these genetic alterations were related to the prognosis. Herein by performing whole-exome sequencing of 48 SCCE and 64 SCLC tumor samples, respectively we have shown that the number of driver mutations in SCCE was significantly lower than in SCLC (p = 0.0042). In SCCE, 46% of recurrent driver mutations were clonal, which occurred at an early stage during tumorigenesis, while 16 driver mutations were found clonal in SCLC. NOTCH1/3, PIK3CA, and ATM were specifically clonal in SCCE, while TP53 was clonal in SCLC. The total number of clonal mutations differed between two cancers and presented lower in SCCE compared to SCLC (p = 0.0036). Moreover, overall survival (OS) was shorter in patients with higher numbers of clonal mutations for both cancers. In summary, SCCE showed distinct mutational background and clonal architecture compared with SCLC. Organ-specific clonal events revealed different molecular mechanisms underlying tumorigenesis, tumor development, patients’ prognosis, and possible variations in therapeutic outcomes to candidate treatments. |
url |
https://doi.org/10.1038/s41419-021-03754-0 |
work_keys_str_mv |
AT zhengbosong distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT yuepingliu distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT guopingcheng distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT lianpengchang distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT zichengyu distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT mingchen distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung AT gangchen distinctmutationalbackgroundsandclonalarchitecturesimplicatedprognosticdiscrepanciesinsmallcellcarcinomasoftheesophagusandlung |
_version_ |
1721439870460624896 |